Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Utility of exome sequencing in routine care for metastatic colorectal cancer.

Molecular and clinical oncology

D'Agay MG, Galland L, Tharin Z, Truntzer C, Ghiringhelli F.
PMID: 34631054
Mol Clin Oncol. 2021 Nov;15(5):229. doi: 10.3892/mco.2021.2392. Epub 2021 Sep 10.

Metastatic colorectal cancer (mCRC) is a heterogenous disease and its prognosis depends on clinical features, such as tumor sidedness, and whether it is metachronous or synchronous. However, little is known about the overall genomic characterization of mCRC in these...

Cite
D'Agay MG, Galland L, Tharin Z, et al. Utility of exome sequencing in routine care for metastatic colorectal cancer. Mol Clin Oncol. 2021;15(5):229doi: 10.3892/mco.2021.2392.
D'Agay, M. G., Galland, L., Tharin, Z., Truntzer, C., & Ghiringhelli, F. (2021). Utility of exome sequencing in routine care for metastatic colorectal cancer. Molecular and clinical oncology, 15(5), 229. https://doi.org/10.3892/mco.2021.2392
D'Agay, Melchior De Giraud, et al. "Utility of exome sequencing in routine care for metastatic colorectal cancer." Molecular and clinical oncology vol. 15,5 (2021): 229. doi: https://doi.org/10.3892/mco.2021.2392
D'Agay MG, Galland L, Tharin Z, Truntzer C, Ghiringhelli F. Utility of exome sequencing in routine care for metastatic colorectal cancer. Mol Clin Oncol. 2021 Nov;15(5):229. doi: 10.3892/mco.2021.2392. Epub 2021 Sep 10. PMID: 34631054; PMCID: PMC8461624.
Copy Download .nbib Format: NLM
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study.

BMJ open gastroenterology

Danese S, Hart A, Dignass A, Louis E, D'Haens G, Dotan I, Rogler G, D'Agay L, Iannacone C, Peyrin-Biroulet L.
PMID: 27239329
BMJ Open Gastroenterol. 2016 May 17;3(1):e000092. doi: 10.1136/bmjgast-2016-000092. eCollection 2016.

INTRODUCTION: A study has been developed to assess the use and effectiveness of budesonide MMX for mild-to-moderate active ulcerative colitis (UC) in routine clinical practice.METHODS AND ANALYSIS: A prospective, multicentre, observational, cohort study of 300 patients prescribed budesonide MMX...

Cite
Danese S, Hart A, Dignass A, et al. Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study. BMJ Open Gastroenterol. 2016;3(1):e000092doi: 10.1136/bmjgast-2016-000092.
Danese, S., Hart, A., Dignass, A., Louis, E., D'Haens, G., Dotan, I., Rogler, G., D'Agay, L., Iannacone, C., & Peyrin-Biroulet, L. (2016). Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study. BMJ open gastroenterology, 3(1), e000092. https://doi.org/10.1136/bmjgast-2016-000092
Danese, Silvio, et al. "Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study." BMJ open gastroenterology vol. 3,1 (2016): e000092. doi: https://doi.org/10.1136/bmjgast-2016-000092
Danese S, Hart A, Dignass A, Louis E, D'Haens G, Dotan I, Rogler G, D'Agay L, Iannacone C, Peyrin-Biroulet L. Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study. BMJ Open Gastroenterol. 2016 May 17;3(1):e000092. doi: 10.1136/bmjgast-2016-000092. eCollection 2016. PMID: 27239329; PMCID: PMC4873945.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries